SCHEMBL5474228

SCHEMBL5474228

CN(CC[C@@H]1CO1)Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
PRMT8 Q9NR22 1/20 0.53
SIGMAR1 Q99720 1/20 0.49
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 4/20 0.44
TSHR P16473 3/20 0.44
MAOB P27338 3/20 0.43
LMNA P02545 2/20 0.43
USP2 O75604 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAOA P21397 1/20 0.43
PYCR1 P32322 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
BLM P54132 1/20 0.42
LTA4H P09960 1/20 0.42
AOC3 Q16853 1/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474230 1.00 CARM1 (0.53) CARM1PRMT6PRMT8SIGMAR1MEN1
SCHEMBL5482881 1.00 CARM1 (0.53) CARM1PRMT6PRMT8SIGMAR1MEN1
SCHEMBL20695781 0.82 MEN1 (0.46) MEN1KMT2AALDH1A1TSHRKDM4E
SCHEMBL4662600 0.82 MEN1 (0.46) MEN1KMT2AALDH1A1TSHRKDM4E
SCHEMBL4334028 0.82 ALDH1A1 (0.49) CARM1PRMT6PRMT8SIGMAR1ALDH1A1
SCHEMBL4326995 0.82 ALDH1A1 (0.49) CARM1PRMT6PRMT8SIGMAR1ALDH1A1
SCHEMBL3665986 0.82 ALDH1A1 (0.49) CARM1PRMT6PRMT8SIGMAR1ALDH1A1
SCHEMBL5310877 0.79 SIGMAR1 (0.53) CARM1PRMT6PRMT8SIGMAR1MAOB
SCHEMBL7055109 0.77 CARM1 (0.75) CARM1PRMT6PRMT8SIGMAR1ALDH1A1
Hydrochloric Acid SCHEMBL10513298 0.75 DRD4 (0.64) CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070072859-A1 Pharmaceutical compounds ELI LILLY AND COMPANY (US) 2007-03-29 US disclosed
US-20070072859-A1 Pharmaceutical compounds ELI LILLY AND COMPANY (US) 2007-03-29 US disclosed
US-20070072859-A1 Pharmaceutical compounds ELI LILLY AND COMPANY (US) 2007-03-29 US disclosed
EP-1725518-A1 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2006-11-29 EP disclosed
WO-2005092835-A1 PHARMACEUTICAL COMPOUNDS ELI LILLY AND COMPANY (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072859-A1 Pharmaceutical compounds ADRB3, HTR3C, SLC6A2 CARM1 2512/4885PRMT6 3286/4885PRMT8 3125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.